ATRC vs IR · rev $294.9M vs P/E 49, rev $3.90B
AtriCure Inc (ATRC) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported ATRC revenue for 2026-06-30 was $294.9M. Net income was $9.1M. ATRC currently screens at market cap $1.37B.
Latest reported IR revenue for 2026-06-30 was $3.90B. Net income was $448.9M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
ATRC currently screens at market cap $1.37B. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the ATRC and IR stock pages for the full models.
Not investment advice.